These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 34804944)
21. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma. Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371 [TBL] [Abstract][Full Text] [Related]
22. A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma. Jiang A; Wu X; Wang D; Wang A; Dong K; Liu B; Qu L; Luo P; Wang J; Tong Q; Wang L Front Immunol; 2022; 13():935595. PubMed ID: 35935986 [TBL] [Abstract][Full Text] [Related]
23. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics. Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L Front Oncol; 2022; 12():941724. PubMed ID: 36212395 [TBL] [Abstract][Full Text] [Related]
24. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma. Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS Front Immunol; 2022; 13():861328. PubMed ID: 35479084 [TBL] [Abstract][Full Text] [Related]
25. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma. Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838 [TBL] [Abstract][Full Text] [Related]
26. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma. Zhong W; Zhang F; Huang C; Lin Y; Huang J Front Oncol; 2020; 10():591254. PubMed ID: 33324563 [TBL] [Abstract][Full Text] [Related]
27. Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma. Li CS; Lu ZZ; Fang DL; Zhou WJ; Wei J Transl Androl Urol; 2021 Jun; 10(6):2478-2492. PubMed ID: 34295734 [TBL] [Abstract][Full Text] [Related]
28. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187 [TBL] [Abstract][Full Text] [Related]
29. Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response. Cai Y; Li K; Lin J; Liang X; Xu W; Zhan Z; Xue S; Zeng Y; Chai P; Mao Y; Song Z; Han L; Song Y; Zhang X; Wang H Front Immunol; 2022; 13():910490. PubMed ID: 35784306 [TBL] [Abstract][Full Text] [Related]
30. Generation and Analysis of Pyroptosis-Based and Immune-Based Signatures for Kidney Renal Clear Cell Carcinoma Patients, and Cell Experiment. Lin G; Feng Q; Zhan F; Yang F; Niu Y; Li G Front Genet; 2022; 13():809794. PubMed ID: 35281845 [No Abstract] [Full Text] [Related]
31. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment. Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N Front Genet; 2021; 12():706661. PubMed ID: 34712264 [No Abstract] [Full Text] [Related]
32. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303 [TBL] [Abstract][Full Text] [Related]
33. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma. Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143 [TBL] [Abstract][Full Text] [Related]
34. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma. Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133 [TBL] [Abstract][Full Text] [Related]
35. A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma. Jiang A; Luo P; Chen M; Fang Y; Liu B; Wu Z; Qu L; Wang A; Wang L; Cai C Cell Biosci; 2022 Dec; 12(1):209. PubMed ID: 36581992 [TBL] [Abstract][Full Text] [Related]
36. Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis. Zhou L; Ye J; Wen F; Yu H Dis Markers; 2022; 2022():4033583. PubMed ID: 35320950 [TBL] [Abstract][Full Text] [Related]
37. Definition and verification of novel metastasis and recurrence related signatures of ccRCC: A multicohort study. Jiang A; Pang Q; Gan X; Wang A; Wu Z; Liu B; Luo P; Qu L; Wang L Cancer Innov; 2022 Aug; 1(2):146-167. PubMed ID: 38090653 [TBL] [Abstract][Full Text] [Related]
38. Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients. Li Z; Liu Y; Lin B; Yan W; Yi H; Wang H; Wei Y Front Genet; 2022; 13():925338. PubMed ID: 35937993 [No Abstract] [Full Text] [Related]
39. T cell proliferation-related genes: Predicting prognosis, identifying the cold and hot tumors, and guiding treatment in clear cell renal cell carcinoma. Huang H; Cai Y; Hong X; Gao W; Tang J; Zhang S; Xu Z Front Genet; 2022; 13():948734. PubMed ID: 36118894 [No Abstract] [Full Text] [Related]
40. Single-Cell Sequencing to Identify Six Heat Shock Protein (HSP) Genes-Mediated Progression Subtypes of Clear Cell Renal Cell Carcinoma. Li Q; Lu M; Zhang Z; Zhang R Int J Gen Med; 2021; 14():3761-3773. PubMed ID: 34326662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]